Rights advocates confront experts,seek medical assistance for Dengvaxia vaccinees

admin   •   February 13, 2018   •   3365

MANILA, Philippines — Parents of Dengvaxia vaccinees are bewildered by the differing opinions and views of doctors regarding the controversial vaccine.

That is why they have decided to discuss and clarify things with the UP-PGH expert panel.

According to the Coalition for People’s Right to Health (CPRH), they want to help these parents in seeking free medical assistance, justice, and indemnification.

“This is an independent forum sponsored by the Coalition of People’s Right to Health. There are reactors, there will also be lawyers,” said Dr. Eleonor Jara, a co-convenor.

“This is more for the coalition, it’s really pro-people. Whatever will be more beneficial to our countrymen is our stand,” she added.

Among those seeking help is Norman Castillote, the faculty president of Nagpayong Elementary School in Pasig City which had an estimated 1,000 vaccinees in 2016.

He said that the Dengvaxia issue has affected their students in various ways, such as refusing other free medical services offered to them like deworming.

The vaccinees have also become objects of ridicule.

“Binubully silang ng mga hindi na-vaccinan, ‘Uy mamamatay ka na kasi na- vaccinan ka,’ eh may effect iyon sa kanila. Nagko-cause iyon ng hindi pagkakaunawaan sa loob ng klase. Pina- pacify ko nalang sila para hindi sila mag- away,” said Castillote.

(Kids who have not been vaccinated by Dengvaxia would heckle vaccinees saying, ‘Oh, you’re going to die because you’ve been vaccinated.’ It affects vaccinees and causes misunderstanding in class. I just pacify them to avert conflict.)

The forum with the UP- PGH expert panel headed by Dr. Juliet Sio-Aguilar, lasted for four hours. — Aiko Miguel | UNTV News & Rescue


Health groups urge better health care system for COVID-19 response

Aileen Cerrudo   •   March 16, 2021

MANILA, Philippines—Various health groups are urging the national government to boost its health care system, especially for its coronavirus disease (COVID-19) response.

Coalition for People’s Right to Health (CPRH) Co-convenor Dr. Joshua San Pedro said the country should not only rely on vaccines as a way to fight the virus. The group has also called on the national government to provide assistance to far-flung areas that have limited access to health services.

“States are making mistakes kung vaccination lang ang kanyang aasahan. Talagang kailangang kailangan na mapalakas pa rin ang public health measures ensuring na umaabot sa kumonidad ang usaping pangkalusugan at serbiyong pangkalusugan (States are making mistakes if they will only rely on vaccines. We really need to boost our public health measures, ensuring it will reach communities),” he said.

Mass testing, San Pedro added, is key in preventing the spread of COVID-19. He also lamented that the national government-imposed travel restrictions a bit late.

Meanwhile, Filipino Nurses United has also called on the government to hire more nurses as several COVID-19 hospitals are at their full capacity, which increases the workload of nurses.

“We have received a report from our members that one nurse cares for at least 12 patients and now they are positive for COVID-19. Ideally, one nurse will care for at least three patients in a COVID-19 Ward. One nurse and one patient for critical and severe cases of COVID,” according to Maristela Abenajor of Filipino Nurses United. AAC (with reports from Janice Ingente)

DOH agrees with FDA decision to ban Dengvaxia in Phl

Maris Federez   •   August 22, 2019

A Filipino nurse prepares to administer an anti-dengue vaccine during a nationwide vaccination at a school in the flood-prone city of Marikina, east of Manila, Philippines, 04 April 2016. (Photoville International / FILE)

The Department of Health (DOH) has rejected the request of Sanofi Pasteur to overturn the decision of the Food and Drug Administration (FDA) to ban the use of Dengvaxia vaccine in the Philippines.

With this, the DOH approved the ruling of the FDA to permanently revoke the certificate of product registration of Dengvaxia for Sanofi’s failure to submit the necessary post-approval requirements.

“The decision concerns Sanofi’s complete disregard of FDA regulations, which were precisely put in place by law to ensure safety,” DOH Secretary Francisco Duque III said in a statement.

Although Sanofi was able to submit the first two versions of its risk management plans (RMP), the pharmaceutical company failed to submit the third and final version of the plan.

The DOH said, however, that Sanofi may apply for a new certificate of product registration (CPR) for Dengvaxia but this must be in accordance with the FDA regulations.

“Given that Dengvaxia is an innovative drug, the importance of complying with these post-marketing commitments is critical to public safety,” the statement added.

Meanwhile, the department has assured that it continues to address the increasing cases of dengue in the country. /mbmf

Sanofi Pasteur optimistic Dengvaxia will be restored in PH market

Aileen Cerrudo   •   August 15, 2019

French Pharmaceutical firm, Sanofi Pasteur expressed optimism that the Dengvaxia vaccine will be restored in the Philippine market.

In a statement, Sanofi Pasteur Philippines General Manager Jean Antoine Zinsou said they are open for a discussion with the Food and Drug Administration (FDA) and the Department of Health (DOH).

He also clarified that Dengvaxia is safe and effective to use.

According to Zinsou, the said vaccine was only banned in the Philippines because of incomplete documents or due to “administrative consideration.”

“We definitely need to settle this issue. One way to do it is to discuss with FDA and see what is needed to have this revocation lifted,” he said.

Zinsou also said Dengvaxia is registered in 20 countries across the globe and is acknowledged by the United States Food Drug Administration and the World Health Organization (WHO).

Meanwhile, Sanofi agrees with the DOH that Dengvaxia is not a solution to the Dengue epidemic in the country.

READ: Dengvaxia won’t bring dengue cases down – DOH

“The vaccines that we are mentioning is not a solution or a silver bullet for the ongoing outbreak. We are open to any discussion with the health authorities to see what is needed, what do they need for the future,” Zinsou said.

In February this year, the FDA revoked the certificate of product registration of Dengvaxia.

Sanofi already filed an appeal two weeks ago and the DOH will release their decision on the issue on August 19.—AAC (with reports from Aiko Miguel)


The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)


UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.